T. Rowe Price Associates’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Sell |
|
|||||
|
2025
Q1 | $23M | Sell |
|
|||||
|
2024
Q4 | $88.7M | Sell |
|
|||||
|
2024
Q3 | $228M | Sell |
|
|||||
|
2024
Q2 | $436M | Sell |
|
|||||
|
2024
Q1 | $491M | Buy |
|
|||||
|
2023
Q4 | $253M | Buy |
|
|||||
|
2023
Q3 | $220M | Buy |
|
|||||
|
2023
Q2 | $182M | Sell |
|
|||||
|
2023
Q1 | $209M | Sell |
|
|||||
|
2022
Q4 | $329M | Sell |
|
|||||
|
2022
Q3 | $468M | Sell |
|
|||||
|
2022
Q2 | $2.4B | Sell |
|
|||||
|
2022
Q1 | $3.31B | Buy |
|
|||||
|
2021
Q4 | $3.16B | Sell |
|
|||||
|
2021
Q3 | $3.1B | Buy |
|
|||||
|
2021
Q2 | $2.5B | Sell |
|
|||||
|
2021
Q1 | $2.87B | Sell |
|
|||||
|
2020
Q4 | $2.86B | Sell |
|
|||||
|
2020
Q3 | $2.75B | Sell |
|
|||||
|
2020
Q2 | $2.44B | Sell |
|
|||||
|
2020
Q1 | $1.54B | Sell |
|
|||||
|
2019
Q4 | $2.3B | Buy |
|
|||||
|
2019
Q3 | $2.13B | Sell |
|
|||||
|
2019
Q2 | $2.03B | Buy |
|
|||||
|
2019
Q1 | $2.04B | Sell |
|
|||||
|
2018
Q4 | $1.77B | Sell |
|
|||||
|
2018
Q3 | $1.91B | Sell |
|
|||||
|
2018
Q2 | $1.87B | Sell |
|
|||||
|
2018
Q1 | $1.77B | Buy |
|
|||||
|
2017
Q4 | $1.93B | Buy |
|
|||||
|
2017
Q3 | $1.61B | Buy |
|
|||||
|
2017
Q2 | $1.9B | Sell |
|
|||||
|
2017
Q1 | $1.89B | Buy |
|
|||||
|
2016
Q4 | $1.74B | Buy |
|
|||||
|
2016
Q3 | $1.6B | Buy |
|
|||||
|
2016
Q2 | $1.27B | Buy |
|
|||||
|
2016
Q1 | $739M | Buy |
|
|||||
|
2015
Q4 | $610M | Buy |
|
|||||
|
2015
Q3 | $603M | Buy |
|
|||||
|
2015
Q2 | $507M | Buy |
|
|||||
|
2015
Q1 | $294M | Buy |
|
|||||
|
2014
Q4 | $231M | Buy |
|
|||||
|
2014
Q3 | $163M | Buy |
|
|||||
|
2014
Q2 | $142M | Buy |
|
|||||
|
2014
Q1 | $67.5M | Buy |
|
|||||
|
2013
Q4 | $2.08M | Hold |
|
|||||
|
2013
Q3 | $1.92M | Sell |
|
|||||
|
2013
Q2 | $1.87M | Buy |
|